High Risk Non-Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch High Risk Non-Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma (NCT00994643) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2009-02-05 |
Track High Risk Non-Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.